Welcome to the Department of Human Oncology (DHO) at the University of Wisconsin.
We provide comprehensive radiation oncology services with dedication to improve the outcome for cancer patients using state-of-the-art treatment techniques combined with highly compassionate care. Our clinical focus is on each individual cancer patient and their families; however, our mission extends more broadly to include cutting-edge research and advanced training for the next generation of MD and PhD students to ensure cancer therapy improvements for the future.
Paul M. Harari, MD, FASTRO
Jack Fowler Professor and Chairman
Department of Human Oncology
NEWS
DHO and Radiology Advance Collaborations with New MRI Scanner
The Departments of Human Oncology and Radiology recently unveiled a new MRI scanner in the radiation oncology clinic at University Hospital. This machine will enhance patient care and provide opportunities for multidisciplinary collaboration aimed at advancing MRI use in radiation oncology. Read more.
Department Gets into the Halloween Spirit
The UW Health Radiation Oncology Clinic celebrated Halloween with costumes and a Pumpkin Decorating Contest, creating a festive environment for patients, families, and staff. Read more.
Remembering Kelly Clifton, Human Oncology Professor Emeritus
Dr. Kelly Clifton, a professor emeritus in the Department of Human Oncology who helped establish the department’s excellence in radiation biology and carcinogenesis and mentored scientists who went on to highly successful research careers, died on August 24 in Madison. He was 93. Read more.
Drs. Zachary Morris and Jamey Weichert co-lead UW Team Earning $12.5 Million NIH P01 Grant
Dr. Zachary Morris, vice chairman in the Department of Human Oncology and Dr. Jamey Weichert, professor in the Department of Radiology, along with a talented team of UW researchers, have earned a five-year, $12.5 million National Institutes of Health Research Program (P01) Grant (plus $2 million in institutional matching funds) to study the combined use of immunotherapy and targeted radionuclide therapy (TRT) to treat metastatic cancer. Read more.
Dr. Randy Kimple to Lead Phase I Clinical Trial of a Therapy for Dry Mouth in Head and Neck Cancer Patients
Dr. Randy Kimple, associate professor in the Department of Human Oncology, will lead a Phase I clinical trial of a new cell therapy for radiation-induced xerostomia, or dry mouth. Xerostomia is a common long-term side effect of radiation therapy for head and neck cancer that can result in problems eating, speaking and sleeping and can cause pain, fatigue and contribute to tooth decay. Read more.
Find Us in the Community
Wisconsin Head and Neck Cancer SPORE
The Wisconsin Head and Neck SPORE is designed to promote translational laboratory and clinical research to improve overall outcome for patients with Head and Neck Cancer (HNC).
The Ride for Cancer Research: September 27, 2020
Thank you to all riders and supporters for The Ride 2019! We had another record year, bringing us to nearly $1.2 million raised in 4 years!
2019 Milestones:
>$407,389 raised for cancer research
>1,626 registered riders
>200 volunteers
